Poly Medicure Limited (POLYMED) Stock Statistics & Valuation Metrics

Poly Medicure Limited has a market cap or net worth of ₹208.48B. The enterprise value is ₹220.47B.

Poly Medicure Limited has 101,325,714 shares outstanding. The number of shares has decreased by -2.65% in one year.

Poly Medicure Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 11.15%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Poly Medicure Limited had revenue of 16.70B and earned 3.39B in profits. Earnings per share was 34.13.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Poly Medicure Limited pays an annual dividend of ₹3, resulting in a dividend yield of 0.15%

Poly Medicure Limited upcoming earnings date is Aug 8, 2025, TBA (Confirmed).

Poly Medicure Limited as a current ratio of 5.18, with Debt / Equity ratio of 6.52%

In the past 12 months, Poly Medicure Limited has paid 1.14B in taxes.

Poly Medicure Limited EV to EBITDA ratio is 47.18, with an EV/FCF ratio of -236.07.

Poly Medicure Limited has ₹12.08B in cash and marketable securities with ₹1.80B in debt, giving a net cash position of -₹10.28B billion.

Gross margin is 55.44%, with operating margin of 26.79%, and net profit margin of 20.27%.

The average price target for Poly Medicure Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―